Seed Co., Ltd. AI Stock Analysis
Want to see JP:7743 full AI Analyst Report?
Seed Co., Ltd. (7743) AI Stock Analysis
Seed Co., Ltd.
(TSE/TYO:7743)
The score is held back primarily by weakened financial quality—rising leverage and materially negative free cash flow—despite a return to profitability. Strong technical momentum supports the score, but extremely overbought indicators raise near-term risk. Valuation is broadly reasonable (P/E ~20) with a modest dividend yield (~2%), providing moderate support.
Seed Co., Ltd. (7743) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 23.79B
- Dividend Yield
- 1.91%
- Average Volume (3M)
- 260.94K
- Price to Earnings (P/E)
- 21.8
- Beta (1Y)
- 0.51
- Revenue Growth
- 4.13%
- EPS Growth
- -39.39%
- Country
- Japan
- Employees
- 1,048
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Instruments & Supplies
Seed Co., Ltd. Business Overview & Revenue Model
Company Description
SEED Co.,Ltd. is an international manufacturer and supplier specializing in a broad spectrum of ophthalmic products. The company's extensive range includes various contact lenses, lens care solutions, fashionable spectacle frames, and other vision en...
How the Company Makes Money
Seed Co., Ltd. makes money mainly by selling contact lenses and related eye-care products. Revenue is generated from (1) sales of contact lenses (e.g., disposable and other lens types) and (2) sales of ancillary products associated with contact lens...
Seed Co., Ltd. Financial Statement Overview
Summary
Income statement trends are mixed (return to profitability and solid mid-40% gross margins, but net margin has compressed to ~3% and profitability has moderated). Balance sheet risk has increased with sharply higher leverage (debt-to-equity ~2.1x). Cash flow is the largest concern: free cash flow turned negative and is deeply negative in TTM, reducing flexibility amid higher debt.
Income Statement
62PositiveBalance Sheet
46NeutralCash Flow
34Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 34.24B | 33.94B | 33.23B | 32.40B | 30.59B | 28.84B |
| Gross Profit | 15.53B | 15.22B | 14.63B | 14.18B | 11.62B | 12.01B |
| EBITDA | 5.36B | 4.76B | 5.05B | 5.12B | 2.83B | 4.45B |
| Net Income | 1.09B | 1.14B | 1.09B | 1.96B | -316.09M | 1.15B |
Balance Sheet | ||||||
| Total Assets | 66.13B | 62.50B | 51.76B | 49.57B | 40.01B | 41.79B |
| Cash, Cash Equivalents and Short-Term Investments | 5.85B | 4.21B | 7.12B | 9.89B | 4.94B | 3.88B |
| Total Debt | 39.57B | 28.47B | 26.26B | 24.18B | 20.89B | 22.04B |
| Total Liabilities | 47.05B | 42.90B | 33.38B | 31.92B | 27.87B | 29.25B |
| Stockholders Equity | 19.08B | 19.27B | 18.06B | 17.36B | 11.86B | 12.26B |
Cash Flow | ||||||
| Free Cash Flow | -6.78B | -438.07M | -1.70B | 2.19B | 2.79B | 2.15B |
| Operating Cash Flow | 2.95B | 2.69B | 2.98B | 6.02B | 3.35B | 3.27B |
| Investing Cash Flow | -10.11B | -3.84B | -4.57B | -3.76B | -440.73M | -881.61M |
| Financing Cash Flow | 6.74B | -1.91B | -1.13B | 2.64B | -1.82B | -2.42B |
Seed Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7743, the sentiment is Positive. The current price of 786.00 is above the 20-day moving average (MA) of 785.75, above the 50-day MA of 785.20, and above the 200-day MA of 598.99, indicating a bullish trend. The MACD of 4.85 indicates Positive momentum. The RSI at 72.47 is Negative, neither overbought nor oversold. The STOCH value of 33.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7743.
Seed Co., Ltd. Peers Comparison
Overall Rating
JP:773079Outperform
JP:336074Outperform
JP:304669Neutral
JP:588969Neutral
JP:778055Neutral- JP:774354Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:7730 | 79Outperform | JPY 146.30B | 20.33 | ― | 2.75% | 10.18% | 55.86% |
| JP:3360 | 74Outperform | JPY 218.10B | 16.87 | 9.49% | 2.34% | 6.47% | -3.79% |
| JP:3046 | 69Neutral | JPY 154.98B | 20.45 | 22.48% | 1.51% | 14.41% | -6.42% |
| JP:5889 | 69Neutral | JPY 53.22B | 12.49 | ― | 3.81% | 15.36% | 5.16% |
| JP:7780 | 55Neutral | JPY 145.48B | 19.99 | 7.70% | 1.45% | 5.05% | 50.43% |
| JP:7743 | 54Neutral | JPY 23.79B | 21.83 | ― | 1.91% | 4.13% | -39.39% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7743 | Seed Co., Ltd. | 786.00 | 232.61 | 42.03% | |
| JP:3046 | JINS HOLDINGS | 6880.00 | 440.56 | 6.84% | |
| JP:7780 | Menicon Co | 1930.00 | 724.25 | 60.07% | |
| JP:3360 | Ship Healthcare Holdings | 2569.00 | 54.90 | 2.18% | |
| JP:5889 | Japan Eyewear Holdings Co.,Ltd. | 2233.00 | 228.29 | 11.39% | |
| JP:7730 | Mani, Inc. | 1489.00 | 64.46 | 4.52% |
Seed Co., Ltd. Corporate Events
Seed Co., Ltd. Delivers Modest Q1 Sales Growth Amid Profit Decline and Affirms Full-Year Outlook
Seed Co., Ltd. reported consolidated net sales of ¥8,848 million for the three months ended June 30, 2026, a 3.5% year-on-year increase, while operating profit dipped 2.0% to ¥618 million and ordinary profit fell 14.9%. Profit attributable to owners...
Seed Co., Ltd. Scales Back Phase II Investment at Kounosu Contact Lens Plant
Seed Co., Ltd. has revised its Phase II investment plan for Building No. 4 at the Kounosu Laboratory as it continues to upgrade facilities to meet rising global demand for contact lenses. The company is pursuing production lines that reduce labor nee...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 29, 2026